Skip to main content
Premium Trial:

Request an Annual Quote

In Vitro Technologies Awarded US Patent

In Vitro Technologies has been awarded US Patent 7,351,584, “Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids.”
The inventors listed on the patent are Paul Silber, Nancy Cowger, Ana Miller, Lanika Brown, and Albert Li.
According to the abstract, a rotating wall vessel is used as a culture vessel and bioreactor for the cultivation of spheroid hepatocytes that retain many properties of the intact liver. These properties include enzyme activity comparable to fresh cells and long-term maintenance of viability and cellular function for periods as long as several months. The cultured cells may be used to produce hepatocyte products, evaluate the metabolism of potential drug candidates, propagate the hepatitis C virus, and test candidate compounds as inhibitors of this virus.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.